InFlectis BioScience

InFlectis BioScience Overview

Founded 2013
Founded
Status Private
Employees 10
Employees
Latest Deal Type Series A
Latest Deal Amount $6.8M
Latest Deal Amount
Investors 6

InFlectis BioScience General Information

Description

Developer of small molecule drugs intended to improve cellular defense system. The company's small molecule drugs identify preclinical-stage development products that modulate key proteins involved in misfolded protein disorders areas through early proof-of-concept, enabling clients to maximize the commercial value of each of its products, improve patient care and generate significant financial returns to its shareholders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 21 rue La Noue Bras de Fer
  • 44200 Nantes
  • France
+33 02 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InFlectis BioScience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 27-May-2016 $6.8M 00.000 Completed Generating Revenue
2. Seed Round 13-Jan-2015 00.000 00.000 Completed Generating Revenue
1. Grant 01-Jan-2014 $411K Completed Generating Revenue

InFlectis BioScience Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
ContraFect Formerly VC-backed Yonkers, NY 00 00000 000000000 00000
0000000 0000000000 Venture Capital-Backed New Haven, CT 000.00 0000000000 0 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000000 00000000 Venture Capital-Backed Cambridge, MA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Framingham, MA 0 0000 0000000000 0 0000

InFlectis BioScience Executive Team (4)

Name Title Board Seat Contact Info
Philippe Guedat Ph.D Co-Founder, Chief Executive Officer, Chairman, Managing Director & President
Philippe Jaffré Chief Financial Officer
Pierre Miniou Ph.D Co-Founder, Chief Operating Officer & Board Member
Anne Visbecq MD Chief Medical Officer

InFlectis BioScience Board Members (5)

To view InFlectis BioScience‘s full board member team, request access »
Name Representing Role Since
Jérôme Guéret GO Capital (France) Board Member 000 0000
Philippe Guedat Ph.D InFlectis BioScience Co-Founder, Chief Executive Officer, Chairman, Managing Director & President 000 0000
Pierre Miniou Ph.D InFlectis BioScience Co-Founder, Chief Operating Officer & Board Member 000 0000
Taro Inaba Remiges Ventures Board Member 000 0000

1 Former Board Member

InFlectis BioScience Investors (6)

To view InFlectis BioScience‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crédit Mutuel Equity Growth/Expansion Minority 000 0000 000000 0
Remiges Ventures Venture Capital Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
GO Capital (France) Venture Capital Minority 000 0000 000000 0
Participations Besançon Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial